Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease
Study Details
Study Description
Brief Summary
While people of color are an increasing segment of the inflammatory bowel disease (IBD) population, they are currently underrepresented in research, including studies of psychological distress. Appreciation for psychological distress (anxiety, depression, perceived stress) as a driver of IBD activity has led to increased efforts to integrate psychological interventions into IBD medical care. Cognitive behavioral therapy (CBT) is the most studied psychotherapeutic approach in IBD and the one that suggests improvements in mental health and quality of life in those with elevated psychological distress. There are unanswered questions in the use of CBT in IBD: how to leverage digital technology to deliver CBT through internet-based cognitive behavioral therapy (iCBT); how do we consider the social context of individuals from racial and ethnic minority groups who may experience distinct social and structural barriers to acceptance and use of psychological interventions? Thus, this study will qualitatively analyze how factors, such as digital access, mental health stigma, and lived experience with IBD and as racial or ethnic minority influence attitudes toward mental health and iCBT in a cohort of Black and Latino IBD patients with elevated psychological distress. Results will lead to adaptation of a CBT program into an iCBT app to be tested for acceptance/use and to explore effects on psychological and disease-related factors.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Internet-based Cognitive Behavioral Therapy
|
Behavioral: Internet-based Cognitive Behavioral Therapy
Cognitive behavioral therapy (CBT) is a form of psychotherapy in which individuals are taught to identify and modify maladaptive thinking and behavior to improve their psychological status and coping skills. CBT in this trial will be delivered digitally (internet-based).
|
Outcome Measures
Primary Outcome Measures
- Recruitment Rate [8 weeks]
Proportion of eligible patients who enroll into the trial
- Adherence Rate [8 weeks]
Number of activities and weekly sessions completed
Secondary Outcome Measures
- Ilness Perception [8 weeks]
Cognitive and emotional representations formed about one's illness measured via Brief Ilness Perception Questionnaire
- Self-efficacy [8 weeks]
A task-specific construct of the perception of one's ability to manage a given situation measured via PROMIS-Self Efficacy in Managing Emotions questionnaire
- Coping [8 weeks]
Manner of dealing with stress measured via Brief Resilient Coping Scale
- Crohn's Activity [8 weeks]
Level of symptomatic disease measured via Short Crohn's Disease Activity index
- Ulcerative Colitis Activity [8 weeks]
Level of symptomatic disease measured via Simple Clinical Colitis Activity index
- Interleukin-6 level [8 weeks]
Inflammatory biomarker
- Health related quality of life [8 weeks]
Quality of life measured via PROMIS-29 questionnaire
Eligibility Criteria
Criteria
Inclusion Criteria:
-
self-identify as Black or Hispanic/Latino
-
diagnosis of Crohn's disease or ulcerative colitis
-
ability to provide informed consent in English
-
basic computer skills (i.e. ability to self-complete online questionnaire)
-
elevated psychological distress
Exclusion Criteria:
-
severe psychological distress
-
active suicidality, past suicide attempt, or psychiatric hospitalization
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Montefiore Medical Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2022-14155